Eggermont

Full Professor

Biography

lid raad van bestuur	Prinses Maxima Centrum voor Kinderoncologie	1-10-2019
adviseur	CCCMünchen	1-1-2022
adviseur	Deutsche Krebshilfe	1-9-2019
adviseur	DKFZ-Heidelberg	1-1-2020
Editor-in-chief	Eur J Cancer	1-1-2020
chairman board	Fondation Cancer, B	1-1-2015
member	DSMB Melanoma Trials NKI-AvL	1-1-2018
board member	SAB Ludwig Cancer Inst Lausanne	1-1-2022
board member	EORTC Foundation Board	1-1-2011
IDMCimmuno member	IKR/AvL	1-1-2021
Advisory board	Agenus	1-1-2021
Advisory board/DSMB	Biocad	1-1-2020
Advisory board	BioInvent	1-1-2020
IDMC	BioNTech	1-1-2020
Advisory board	CatalYm	1-1-2022
Advisory board	Clover	1-1-2017
Advisory board	Ellipses	1-9-2021
Advisory board	Galecto	1-1-2019
Advisory board/IDMC	GSK	1-1-2020
Advisory board	IO Biotech	1-2-2022
Advisory board	Merck	1-1-2019
IDMC	Pfizer	1-6-2019
Advisory board	Sairopa	1-6-2021
Advisory board	Sellas	1-1-2018
Advisory board	SkylineDx	1-1-2020
Advisory board	TigaTx	1-7-2021
Advisory board	TTxDiscovery	1-10-2021
Lezingen Melanoma	Biocad, BMS, MSD	1-1-2021

Contact

aeggerm3@umcutrecht.nl

Pure profile

Recent publications

All publications

Translating ctDNA into cutaneous melanoma care Glenn Geidel, Nathan Fekade, Katharina Raabe, Daniel J Smit, Laura Adam, Isabel Heidrich, Alessandra Rünger, Julian Kött, Tim Zell, Teresa Amaral, Paolo A Ascierto, Pippa Corrie, Reinhard Dummer, Alexander Eggermont, Jun Guo, Jessica C Hassel, Mathilde Jalving, Douglas B Johnson, Lidija Kandolf, John M Kirkwood, Celeste Lebbé, Rebecca Lee, Georgina V Long, Paul Lorigan, Josep Malvehy, Joanna Mangana, Peter Mohr, Sapna P Patel, Helen Rizos, Caroline Robert, Dirk Schadendorf, Vernon K Sondak, Inge Marie Svane, Alberto Wainstein, Jonathan S Zager, Klaus Pantel, Axel Hauschild, Christoffer Gebhardt,
European Journal of Cancer, 2026, vol. 239

The global cancer crisis Charles M. Balch, Ning Liao, Dennis S.C. Lam, Jeffrey N. Weitzel, Rui Hua Xu, Gerhardt Attard, Paul A. Bunn, Alexander M.M. Eggermont, Jie He, Yuko Kitagawa, Soon Thye Lim, Eduardo Cazap, Bernard Esquivel, Xianqun Fan, Louis W.C. Chow, Edward S.F. Liu, Hector Martinez Said, John E. Niederhuber, Isabel T. Rubio, Ashraf Saad Zaghloul, Oscar G. Arrieta, Riccardo A. Audisio, Geerard L. Beets, Felipe J.F. Coimbra, Jorge E. Gallardo, Judy E. Garber, Alessandro Gronchi, Volker Heinemann, Allison W. Kurian, Miriam Mutebi, Masaki Mori, Funmi I. Olopade, Piotr Rutkowski, Mansoor Saleh, William M. Sanchez, Raymond Sawaya, John F. Thompson, Gerald Tumusiime, Carlos S. Vallejos, David C. Whiteman, Yilong Wu, King David T. Yawe, Nayef Awad Al Zahrani, Odysseas Zoras, Banu K. Arun, Carol J. Fabian, Jeffrey E. Gershenwald, William J. Gradishar, Jin He, V. Suzanne Kimberg, Ronald M.K. Lam, Victor H.F. Lee, Domenica Lorusso, Tony S.K. Mok, N. D. Perrier, Hope S. Rugo, Cornelia Ulrich, Chandrakanth Are, J. Vignat, I. Soerjomataram
ecancermedicalscience, 2026, vol. 20

An updated European organization for research and treatment of cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for merkel cell carcinoma (MCC) Anna Szumera-Ciećkiewicz, Piotr Donizy, Thibault Kervarrec, Witold Skrzyński, Llucia Alos, Natalia Castrejon-De-Anta, Filippo Ugolini, Jakub Mizera, Daniela Mihic-Probst, Martin G. Cook, Bastian Schilling, Piotr Rutkowski, Alexander M.M. Eggermont, Mario Mandalà, Daniela Massi
European Journal of Cancer, 2026, vol. 237

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities Ulrik Ringborg, Joachim von Braun, Julio Celis, Anton Berns, Michael Baumann, Tit Albreht, Nancy Abou-Zeid, Vanderlei Bagnato, Christian Brandts, Chien Jen Chen, Massimiliano di Pietro, Manjit Dosanjh, Thomas Dubois, Alexander Eggermont, Angelika Eggert, Ingemar Ernberg, Sara Faithfull, Johannes Förner, Stefan Fröhling, Manuel Heitor, Leroy Hood, Wei Jiang, Bengt Jönsson, Ravi Kannan, Maria Leptin, Su Li, Peter Lindgren, Douglas Lowy, Jun Ma, Alex Markham, Péter Nagy, Simon Oberst, M. Iqbal Parker, Danielle Rodin, Kevin Ryan, Joachim Schüz, Richard Sullivan, Josep Tabernero, Peter Turkson, Oliver Várhelyi, Harold Varmus, Chijie Wang, Elisabete Weiderpass, Nils Wilking
Molecular Oncology, 2025, vol. 20, p.191-221

Prognostic and predictive value of gastric acid suppressants in the EORTC 1325/KEYNOTE-054 randomized phase III trial of pembrolizumab vs placebo in resected stage III melanoma Emanuel Bührer, Nina Glassee, Michal Kicinski, Oliver J. Kennedy, Christian U. Blank, Georgina V. Long, Victoria G. Atkinson, Stéphane Dalle, Andrew M. Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus J.M. van den Eertwegh, Jean Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Sara Gandini, Sara Valpione, Stefan Suciu, Caroline Robert, Alexander M.M. Eggermont, Paul Lorigan, Mario Mandala
EJC Skin Cancer, 2025, vol. 3

Prognostic and predictive importance of body mass index and type 2 diabetes in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma Oliver John Kennedy, Nina Glassee, Michal Kicinski, Emanuel Bührer, Sara Valpione, Sara Gandini, Stefan Suciu, Christian U. Blank, Georgina V. Long, Victoria G. Atkinson, Stéphane Dalle, Andrew M. Haydon, Andrey Meshcheryakov, Adnan Khattak, Matteo S. Carlino, Shahneen Sandhu, James Larkin, Susana Puig, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Marye Boers-Sonderen, Anna Maria Di Giacomo, Alfonsus J.M. van den Eertwegh, Jean Jacques Grob, Ralf Gutzmer, Rahima Jamal, Alexander C.J. van Akkooi, Caroline Robert, Alexander M.M. Eggermont, Paul Lorigan, Mario Mandala
EJC Skin Cancer, 2025, vol. 3

External positions

Lid SAB - Adviseren - Institut Jules Bordet

Lid SAB - Adviseren - EuroBio

Member Board - Adviseren - Trained Immunity Discovery

Lid IDMC - Adviseren - IQVIA

Lid IDMC - Adviseren - Pfizer

Lid SAB - Adviseren - IO Biotech

CMO - CMO - SAIROPA BV

Lid IDMC - Adviseren - Boehringel Ingelheim

Lid IDMC (independent data monitoring committee) - Adviseren - BioNTech

Voorzitter Steering Committee en Voorzitter Vorstand - Besturen en adviseren - Comprehensive Cancer Center Munich

Lid SAB - Adviseren - CatalYm

Lid SAB (Scientific adboard) - Lid SAB - BIOINVENT

Adviseur Trials - Adviseur Trials - Merck & Co and MSD Europe/NL

Voorzitter - Charity bestuur voorzitten/adviseren - FOCA (FOndation CAncer)

CMO - Adviseren - Skyline DX BV

Coordinator Comprehensive Cancer Center Program - Audits - Deutsche Krebshilfe

Lid Raad van Toezicht - Adviseren - EORTC

President 2014-2019 / Member Steering Cie 2019-2024 - Adviseren, Policy making - European Academy Cancer Sciences (EACS)